Literature DB >> 18534897

Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates.

Mustafa Mansur Tatli1, Coskun Minnet, Abdurrahim Kocyigit, Ahmet Karadag.   

Abstract

Phototherapy is commonly used in the treatment of hyperbilirubinemia in newborns. No serious side effects related to phototherapy have been observed, but concerns regarding its potential to damage DNA have been expressed, based on animal or cell-culture studies. The aim of this study was to investigate, in neonates with hyperbilirubinemia, the possible relation between phototherapy and DNA damage. The study included 33 full-term newborns with non-physiological jaundice and 14 healthy newborns with physiological jaundice as controls. Phototherapy was performed with an array of six fluorescent lamps producing radiation with wavelengths of 480-520 nm at 12 microW/cm(2)/nm. DNA damage in lymphocytes was determined by use of the alkaline comet assay. The DNA damage increased significantly with the duration of phototherapy, as shown by measurements at 24, 48, and 72 h (P<0.001). These findings indicate that phototherapy, widely used in neonatology units, increases DNA damage in newborns. It remains to be seen whether the genotoxic effect observed in the present study can cause any long-term health effect in phototherapy-treated infants in later life.

Entities:  

Mesh:

Year:  2008        PMID: 18534897     DOI: 10.1016/j.mrgentox.2007.06.013

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  17 in total

1.  Prebiotics for the prevention of hyperbilirubinaemia in neonates.

Authors:  Amir Mohammad Armanian; Shayesteh Jahanfar; Awat Feizi; Nima Salehimehr; Mitra Molaeinezhad; Erfan Sadeghi
Journal:  Cochrane Database Syst Rev       Date:  2019-08-13

Review 2.  The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Authors:  Tao Xiong; Yi Qu; Stephanie Cambier; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-04-01       Impact factor: 3.183

3.  Sister Jean Ward, phototherapy, and jaundice: a unique human and photochemical interaction.

Authors:  M J Maisels
Journal:  J Perinatol       Date:  2015-06-11       Impact factor: 2.521

4.  Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model.

Authors:  Kazumichi Fujioka; Flora Kalish; Ronald J Wong; David K Stevenson
Journal:  Pediatr Res       Date:  2015-10-21       Impact factor: 3.756

5.  Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia.

Authors:  M L Donneborg; P K Vandborg; B M Hansen; M Rodrigo-Domingo; F Ebbesen
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

6.  Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia.

Authors:  S Basu; D De; H Dev Khanna; A Kumar
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

7.  Neonatal jaundice and risks of childhood allergic diseases: a population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Chia-Hung Kao
Journal:  Pediatr Res       Date:  2015-05-07       Impact factor: 3.756

8.  Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.

Authors:  Guo-Ying Han; Chun-Yan Li; Hai-Bo Shi; Ji-Ping Wang; Kai-Ming Su; Xin-Lu Yin; Shan-Kai Yin
Journal:  CNS Neurosci Ther       Date:  2014-12-12       Impact factor: 5.243

9.  Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants.

Authors:  Sohier Yahia; Abd Elazeez Shabaan; Mona Gouida; Doaa El-Ghanam; Heba Eldegla; Amal El-Bakary; Hesham Abdel-Hady
Journal:  Eur J Pediatr       Date:  2014-09-12       Impact factor: 3.183

10.  Jaundice, phototherapy and DNA damage in full-term neonates.

Authors:  N Ramy; E A Ghany; W Alsharany; A Nada; R K Darwish; W A Rabie; H Aly
Journal:  J Perinatol       Date:  2015-11-19       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.